No Association Between Adalimumab Use and Heart Failure in Patients with Hidradenitis Suppurativa: A Propensity Matched Study

Authors

Haig Pakhchanian, Department of Dermatology, Sidney Kimmel Medical College: Thomas Jefferson University; Philadelphia, PA, USA; Community Medical Center, Rutgers Robert Wood Johnson Barnabas Health; Toms River, NJ, USA. Electronic address: haig@gwmail.gwu.edu.
Rahul Raiker, George Washington University School of Medicine and Health Sciences; Washington, DC, USA.
Charles DeYoung, Department of Dermatology, Sidney Kimmel Medical College: Thomas Jefferson University; Philadelphia, PA, USA.
Shalini Krishnasamy, Department of Dermatology, Sidney Kimmel Medical College: Thomas Jefferson University; Philadelphia, PA, USA.
Arka Chatterjee, Department of Cardiology, The University of Arizona College of Medicine; Tucson, AZ, USA.
Sherry Yang, Department of Dermatology, Sidney Kimmel Medical College: Thomas Jefferson University; Philadelphia, PA, USA.

Document Type

Journal Article

Publication Date

11-9-2024

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2024.10.069

Keywords

Adalimumab; Biologic Therapy; Cardiovascular Risk; Chronic Inflammatory Disease; Heart Failure (HF); Hidradenitis Suppurativa (HS); Tumor Necrosis Factor-alpha

APA Citation

Pakhchanian, Haig; Raiker, Rahul; DeYoung, Charles; Krishnasamy, Shalini; Chatterjee, Arka; and Yang, Sherry, "No Association Between Adalimumab Use and Heart Failure in Patients with Hidradenitis Suppurativa: A Propensity Matched Study" (2024). GW Authored Works. Paper 6018.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6018

Department

School of Medicine and Health Sciences Resident Works